You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 7, 2025

Details for Patent: RE37564


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE37564
Title: Composition for contraception
Abstract:A combination product for oral contraception is disclosed comprising an estrogen selected from 2.0 to 6.0 mg of 17.beta.-estradiol and 0.020 mg of ethinylestradiol; and a gestagen selected from .[.0.25 to 0.30.]. .Iadd.2.5 to 3.0 .Iaddend.mg of drospirenone and .[.0.1 to 0.2.]. .Iadd.1 to 2 .Iaddend.mg of cyproterone acetate, followed by 5 or 4 pill-free or sugar pill days.
Inventor(s): Spona; Jurgen (Vienna, AT), Dusterberg; Bernd (Berlin, DE), Ludicke; Frank (Geneva, CH)
Assignee: Schering Aktiengesellschaft (Berlin, DE)
Application Number:09/503,952
Patent Claim Types:
see list of patent claims
Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex landscape of U.S. patents, understanding the scope and claims of a patent is crucial for inventors, patent attorneys, and businesses alike. This article delves into the key aspects of patent scope, claims, and the broader patent landscape, using the context of U.S. Patent RE37564 as a reference point, although specific details of this patent are not provided here.

What are Patent Claims?

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. These claims must be clear, concise, and supported by the patent's specification[1].

Types of Claims

  • Independent Claims: These claims stand alone and do not depend on other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims refer back to and further limit an independent claim. They narrow down the scope of the invention[3].

Determining Patent Scope

Patent scope is a critical metric in evaluating the breadth and validity of a patent. It can be measured using various metrics:

Independent Claim Length and Count

Research has shown that independent claim length and count are simple yet effective metrics for measuring patent scope. Patents with narrower claims, as indicated by shorter independent claims and fewer independent claims, tend to have a higher probability of grant and a shorter examination process[5].

Patent Maintenance Payments and Forward Citations

Patents that require higher maintenance payments and receive more forward citations often indicate a broader and more impactful patent scope. These metrics suggest the patent's relevance and influence in the field[5].

The Role of Conception in Inventorship

Inventorship is a vital aspect of patent law, and it is primarily determined by the conception of the invention. Conception is defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention. This idea must be sufficient for one with ordinary skill in the field to reduce it to practice without extensive research or experimentation[1].

Collaborative Efforts

Inventorship can involve collaborative efforts where two or more persons work together to produce the invention. However, merely reducing an invention to practice or performing routine experiments does not qualify someone as an inventor[1].

Errors in Inventorship

Errors in identifying inventors can have severe consequences, including the invalidation of the patent if there is deceptive intent. Correcting inventorship errors is possible, but fraudulently obtained patents remain unenforceable[1].

Reissue Patents and Corrections

In cases where a patent needs to be amended or corrected, reissue patents can be granted. However, reissue patents cannot enlarge the scope of the original claims unless applied for within two years of the original patent grant. Corrections due to mistakes by the Patent and Trademark Office can be made through certificates of correction, which become part of the original patent[2].

Continuation Procedures

Patent applicants often use continuation procedures to refine their applications. These include Requests for Continued Examination (RCEs), continuations-in-part (CIPs), and divisional applications. These procedures allow applicants to address examiner feedback, introduce new subject matter, or separate distinct inventions, all while potentially retaining the priority date of the original application[4].

Patent Allowance Rates

The probability of receiving a U.S. patent varies based on several factors, including the technology field, the size of the entity filing the application, and the use of continuation procedures. Studies have shown that about 31% of progenitor applications utilize at least one continuation procedure, and the overall allowance rate for progenitor applications can be significantly influenced by these procedures[4].

Impact of Examination Process on Patent Scope

The patent examination process often narrows the scope of patent claims. Research indicates that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. The duration of the examination process can also impact the final scope of the patent claims[5].

Protecting Intervening Rights

When a reissue patent is granted, it is crucial to protect intervening rights. The law ensures that individuals who made, purchased, or used the patented invention before the reissue are not adversely affected unless the reissue claims are infringed[2].

Key Takeaways

  • Clear and Concise Claims: Patent claims must be clear, concise, and supported by the specification.
  • Scope Metrics: Independent claim length and count are effective metrics for measuring patent scope.
  • Inventorship: Conception is key in determining inventorship, and errors can have severe consequences.
  • Reissue and Corrections: Reissue patents and certificates of correction can amend or correct original patents.
  • Continuation Procedures: These procedures can refine applications and retain priority dates.
  • Examination Process: The examination process can narrow the scope of patent claims.

FAQs

What are the key elements of patent claims?

Patent claims must be clear, concise, and supported by the patent's specification. They define the scope of the invention for which protection is sought.

How is patent scope measured?

Patent scope can be measured using metrics such as independent claim length and count, patent maintenance payments, and forward citations.

What is the significance of conception in inventorship?

Conception is the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention. It is crucial for determining who is an inventor.

Can errors in inventorship be corrected?

Yes, errors in inventorship can be corrected, but if there is deceptive intent, the patent remains unenforceable.

What is the purpose of reissue patents?

Reissue patents are used to amend or correct original patents, but they cannot enlarge the scope of the original claims unless applied for within two years of the original patent grant.

Sources

  1. Determining Inventorship for US Patent Applications - Oregon State University
  2. 35 USC Ch. 25: AMENDMENT AND CORRECTION OF PATENTS - US Code
  3. Patent Claims Research Dataset - USPTO
  4. What Is the Probability of Receiving a US Patent? - Yale Journal of Law and Technology
  5. Patent Claims and Patent Scope - SSRN

More… ↓

⤷  Try for Free


Drugs Protected by US Patent RE37564

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: RE37564

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany43 44 462Dec 22, 1993

International Family Members for US Patent RE37564

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Austria 344038 ⤷  Try for Free
Canada 2179728 ⤷  Try for Free
China 100377713 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.